Eli Lilly, the pharmaceutical company, has received the first approval for the sale of its blockbuster drug Tirzepatide in India. While India has given the initial nod for it mainly for the treatment of type 2 diabetes, it has been used elsewhere to treat weight loss. Here’s what we know about this ‘game-changing’ medication
India one step closer to approving weight-loss drug tirzepatide: What is it? How does it work?
